The last two years have seen unprecedented challenges for health services. How did our response to the covid-19 pandemic impact on personalised care and what has changed as a consequence? This session will look back over the last two years, showcasing the SafeFit trial which was developed in response to the pandemic, highlighting the learning from this innovative work. The session will also look forward to consider how we continue to apply learning to support meaningful personalised care across cancer services now and for the future.